CoMIT: a bioinformatic pipeline for risk-based prediction of COVID-19 test inclusivity

Related articles

1. COVID-19 exposure risks and protective measures in East London’s healthcare and academic sectors: Insights and applications of GloBody technology for infectious disease monitoring

   This article has 29 authors:

   1. Sharmilee Gnanapavan
   2. Mohammad Aboulwafa
   3. Francesca Ammoscato
   4. Michael Andrews
   5. Georgios Alampritis
   6. A. Nazli Asardag
   7. David Baker
   8. Randy Chance
   9. Carrie Chew
   10. Teresa Cutino-Moguel
   11. Anastasia Georgievskaya
   12. Upkar S. Gill
   13. Gavin Giovannoni
   14. Charalambos Hadjicharalambous
   15. Anna He
   16. David W. Holden
   17. Meleri Jones
   18. Madeleine R. Jones
   19. Patrick T. F. Kennedy
   20. Ewan Main
   21. Olivia R. McIver
   22. Triska Miran
   23. Adrienne Morgan
   24. Ankit Patel
   25. Ruth S. Rose
   26. Klaus Schmierer
   27. Justyna Skonieczna
   28. Angray S. Kang
   29. Paul L. Ryan

2. Enhancing Diagnostic Sensitivity: Investigating Molecular Mechanisms of Antigen Rapid Diagnostic Test (AgRDTs) Variability Across SARS-CoV-2 Variants

   This article has 10 authors:

   1. Frank Twum Aboagye
   2. Mawutor Kwame Ahiabu
   3. Maame Ekua Acquah
   4. Queenstar Quarshie
   5. Naa Kumah
   6. Hannah Akahoho
   7. Nfayem Imoro
   8. Abena Enninful
   9. Bill Egyam
   10. Yvonne Ashong

3. Development of Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Protein for COVID-19 Antigen Detection

   This article has 9 authors:

   1. Maurine Mumo Mutua
   2. Bernard N. Kanoi
   3. Steven Ger Nyanjom
   4. Sebastian Musundi
   5. Mark Makau
   6. Shingo Inoue
   7. Samoel Ashimosi Khamadi
   8. Jesse Gitaka
   9. Ernest Apondi Wandera